Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1490 Articles

Lee Jackson | Jan 8, 2016 at 11:05 AM EST

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap…

Chris Lange | Jan 6, 2016 at 10:35 AM EST

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case…

Jon C. Ogg | Jan 4, 2016 at 8:50 AM EST

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow…

Lee Jackson | Dec 28, 2015 at 10:10 AM EST

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life.…

Chris Lange | Dec 28, 2015 at 9:35 AM EST

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical…

Trey Thoelcke | Dec 28, 2015 at 8:20 AM EST

The 6 Most Shorted NYSE Stocks: Short Sellers Still Fleeing GE

General Electric saw its short interest drop sharply again between the November 30 and December 15 settlement dates.

Paul Ausick | Dec 24, 2015 at 1:01 PM EST

The 4 Stocks That Buoyed the DJIA on Thursday

December 24, 2015: Markets opened mixed on Thursday after thin trading and little movement in both Europe and Asia. The…

Lee Jackson | Dec 23, 2015 at 8:25 AM EST

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

24/7 Wall St. screened the Jefferies Franchise Picks list for the top-yielding stocks and found four with outstanding growth potential.

Paul Ausick | Dec 21, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the Dow on Monday

December 21, 2015: Markets opened higher on Monday following a changing of the guard at the top of Spain’s government…

Jon C. Ogg | Dec 21, 2015 at 9:50 AM EST

Dividends Galore: Meet the Preliminary 2016 Dogs of the Dow

At the end of every year, myriad strategies are announced for the coming year. With investors continuing to love dividends,…

Jon C. Ogg | Dec 15, 2015 at 4:52 PM EST

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a…

Lee Jackson | Dec 11, 2015 at 8:25 AM EST

Merrill Lynch Out With Top 10 Stock Picks for 2016

Merrill Lynch is among the first firms to present their top picks for 2016, a decidedly conservative set of picks,…

Chris Lange | Dec 10, 2015 at 8:50 AM EST

Short Interest in Major Pharma Takes a Giant Leap

The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Dec 7, 2015 at 4:09 PM EST

Jefferies Top Pharma Stock Picks for 2016

Brokerage firm Jefferies has released its top pharmaceutical picks for the coming year and what to expect.

Lee Jackson | Dec 7, 2015 at 8:25 AM EST

Merrill Lynch Has 4 Blue-Chip Dividend Stocks to Buy and Hold Forever

With the market very possibly poised for years of sideways trading and single-digit gains, the total return potential from these…

1 … 54 55 56 57 58 … 100

Pfizer : PFE

All Pfizer Articles

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

Major Pharma Short Interest Takes Another Giant Leap Forward

The 6 Most Shorted NYSE Stocks: Short Sellers Still Fleeing GE

The 4 Stocks That Buoyed the DJIA on Thursday

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

The 4 Stocks That Lifted the Dow on Monday

Dividends Galore: Meet the Preliminary 2016 Dogs of the Dow

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Merrill Lynch Out With Top 10 Stock Picks for 2016

Short Interest in Major Pharma Takes a Giant Leap

Jefferies Top Pharma Stock Picks for 2016

Merrill Lynch Has 4 Blue-Chip Dividend Stocks to Buy and Hold Forever

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

3 Stocks With a Yield Over 6% For Passive Income Investors

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

Pfizer : PFE

All Pfizer Articles

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

Major Pharma Short Interest Takes Another Giant Leap Forward

The 6 Most Shorted NYSE Stocks: Short Sellers Still Fleeing GE

The 4 Stocks That Buoyed the DJIA on Thursday

Top-Yielding Jefferies Franchise List Stocks to Buy for 2016

The 4 Stocks That Lifted the Dow on Monday

Dividends Galore: Meet the Preliminary 2016 Dogs of the Dow

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Merrill Lynch Out With Top 10 Stock Picks for 2016

Short Interest in Major Pharma Takes a Giant Leap

Jefferies Top Pharma Stock Picks for 2016

Merrill Lynch Has 4 Blue-Chip Dividend Stocks to Buy and Hold Forever

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

Forget the Labor Market Noise: This Essential Business Utility Stock Is the Ultimate “Set-It-and-Forget-It” Cash Cow

3 Stocks With a Yield Over 6% For Passive Income Investors

Featured Reads

Suze Orman to 54-Year-Old With $600,000: Skip the 1.5% Fee and Manage It Yourself

A $2.5 Million 401(k) at 73 Can Still Cost You Six Figures Without These 3 Moves